Gene Therapy

Latest News

Timon-stock@adobe.com
CMS Launches Value-Based Gene Therapy Program for Sickle Cell Disease

July 16th 2025

CMS is brokering outcomes-based agreements on behalf of Medicaid programs. Thirty-three states, along with Washington, D.C., and Puerto Rico, have signed on, collectively covering about 84% of Medicaid enrollees with sickle cell disease.

Adisak-stock@adobe.com
Gene Therapy Shows Promise for Hereditary Deafness Across Age Groups

July 9th 2025

Funny-stock@abode.com
FDA Lifts Safety Restrictions on CAR T Therapies After Reviewing Real-World Data

July 2nd 2025

 Thananatt-stock@adobe.com
Retinal Disease Gene Therapy Field Remains Nascent Despite Recent Approval

June 23rd 2025

 mat-stock.adobe.com
Patient Advocates Launch Initiative to Bridge Sickle Cell Gene Therapy Knowledge Gaps

June 16th 2025

More News

© 2025 MJH Life Sciences

All rights reserved.